Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 40

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 40
---
 of the private placement warrants, the Company has the obligation to file a registration statement on Form S-1 providing for the
resale by the holders of the private placement warrants of the shares of Common Stock issued and issuable upon exercise of the private
placement warrants.

In connection with the offering, the Company issued
warrants to the placement agent, exercisable to purchase 13,335 shares of Common Stock, representing 5% of the shares purchased at the
closing of the offering, for an aggregate purchase price of $100.00, at an exercise price of $28.125 per share, which is equal to 125%
of the public offering price.

The holders of the placement agent warrants may exercise
the placement agent warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares. The holders of
the placement agent warrants may also exercise the placement agent warrants on a cashless or “net issuance” basis by receiving
a net number of shares calculated pursuant to the formula set forth in the placement agent warrants. The placement agent warrants are
subject to anti-dilution adjustments for stock dividends, stock splits, and reverse stock splits. Pursuant to the terms of the placement
agent warrants, the holders are entitled to piggyback registration rights if the Company proposes to file a new registration statement
under the Securities Act, subject to certain limitations.

| II-3 |

Placement Agent Warrants Issued in Connection with Offering on October 28, 2024

On October 28, 2024, the Company entered into a placement
agency agreement with ThinkEquity LLC, as the placement agent, in connection with the issuance and sale of up to 114,600 shares of the
Common Stock, at a public offering price of $28.30 per share.

In connection with the offering, the Company issued
warrants to the placement agent, exercisable to purchase 5,730 shares of Common Stock, representing 5% of the shares purchased at the
closing of the offering, for an aggregate purchase price of $100.00, at an exercise price of $35.375 per share, which is equal to 125%
of the public offering price.

The holders of the placement agent warrants may exercise
the placement agent warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares. The holders of
the placement agent warrants may also exercise the placement agent warrants on a cashless or “net issuance” basis by receiving
a net number